Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic Melanoma

NCT00308607 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Melanoma

Interventions

DRUG: Bevacizumab (Avastin)
DRUG: dacarbazine
DRUG: interferon-alfa-2a (Roferon-A)

Sponsor

University of Turku